Literature DB >> 7895175

Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule.

H Jiang1, R Ware, A Stall, L Flaherty, L Chess, B Pernis.   

Abstract

Interactions mediated by TCRs expressed on different T cell subsets may play a role in immunoregulation. To investigate this idea, we studied the regulation of superantigen-induced TCR V beta-restricted responses. We asked whether the in vivo regulation of CD4+ V beta 8+ T cells following SEB injection is controlled by CD8+ T cells. We found that in mice deficient in CD8+ T cells, the down-regulation of CD4+ V beta 8+ T cells below baseline is not observed. Moreover, following SEB administration, CD8+ T cells emerge that preferentially kill subpopulations of activated CD4+ V beta 8+ but not CD4+ V beta 8- T cells in vitro. This TCR V beta-specific cytotoxicity is dependent on beta 2-microglobulin and is inhibited by antisera specific for Qa-1 but not by antibody to MHC class Ia. These data suggest the idea that the specificity of immune regulation may involve CD8+ T cell recognition of TCR V beta determinants and Qa-1 molecules expressed on CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895175     DOI: 10.1016/s1074-7613(95)80079-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  59 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.

Authors:  H Jiang; N S Braunstein; B Yu; R Winchester; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.

Authors:  Chiara Romagnani; Gabriella Pietra; Michela Falco; Enrico Millo; Paola Mazzarino; Roberto Biassoni; Alessandro Moretta; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-07       Impact factor: 11.205

4.  Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis.

Authors:  H Jiang; S Curran; E Ruiz-Vazquez; B Liang; R Winchester; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-24       Impact factor: 11.205

Review 5.  Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.

Authors:  Peter E Jensen; Barbara A Sullivan; Lisa M Reed-Loisel; Dominique A Weber
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 6.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

Review 7.  Mechanisms of self-nonself discrimination and possible clinical relevance.

Authors:  Carolin Daniel; Jens Nolting; Harald von Boehmer
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

8.  Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs.

Authors:  Steven G Friedenberg; Greg Buhrman; Lhoucine Chdid; Natasha J Olby; Thierry Olivry; Julien Guillaumin; Theresa O'Toole; Robert Goggs; Lorna J Kennedy; Robert B Rose; Kathryn M Meurs
Journal:  Immunogenetics       Date:  2015-12-28       Impact factor: 2.846

9.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 10.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.